Elevated plasminogen activators are associated with hematoma progression in spontaneous intracerebral hemorrhage
Authors:
- Zhe Kang LawZLZhe Kang Law
- Michael DesboroughMDMichael Desborough
- Kamini RakkarKRKamini Rakkar
- Philip M. BathPBPhilip M. Bath
- Ulvi BayraktutanUBUlvi Bayraktutan
- Nikola SpriggNSNikola Sprigg
Open Access
- 1 March 2020
- journal article
- research article
- Published by KEAI Publishing in Brain Hemorrhages
- Vol. 1 (1) , 75-79
Abstract
No abstract availableKeywords
Funding Information
- Stroke Association
This publication has 6 references indexed in Scilit:
- Increased urokinase and consumption of α2‐antiplasmin as an explanation for the loss of benefit of tranexamic acid after treatment delayJournal of Thrombosis and Haemostasis, 2018
- Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage (TICH-2): an international randomised, placebo-controlled, phase 3 superiority trialThe Lancet, 2018
- Serum D-dimer as a predictor of mortality in patients with acute spontaneous intracerebral hemorrhageJournal of Clinical Neuroscience, 2012
- Memantine Reduces Hematoma Expansion in Experimental Intracerebral Hemorrhage, Resulting in Functional ImprovementJournal of Cerebral Blood Flow & Metabolism, 2006
- Hemostatic Activation in Spontaneous Intracerebral HemorrhageStroke, 2001
- The Peptide Chains of Human PlasminJournal of Biological Chemistry, 1967